Medicud Srl received over €1.3 million (US$1.4 million) in seed funding to support clinical trials and secure regulatory approval of Dryum, its incisional negative pressure wound therapy system.

Financing will support clinical and regulatory development of DRYUM, novel and easy to use incisional negative pressure wound therapy system, with first clinical focus in orthopedic surgeryRegulatory ...